JP2016526920A5 - - Google Patents

Download PDF

Info

Publication number
JP2016526920A5
JP2016526920A5 JP2016533383A JP2016533383A JP2016526920A5 JP 2016526920 A5 JP2016526920 A5 JP 2016526920A5 JP 2016533383 A JP2016533383 A JP 2016533383A JP 2016533383 A JP2016533383 A JP 2016533383A JP 2016526920 A5 JP2016526920 A5 JP 2016526920A5
Authority
JP
Japan
Prior art keywords
replication competent
recombinant replication
competent retrovirus
retrovirus
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016533383A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016526920A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/049831 external-priority patent/WO2015021077A1/en
Publication of JP2016526920A publication Critical patent/JP2016526920A/ja
Publication of JP2016526920A5 publication Critical patent/JP2016526920A5/ja
Pending legal-status Critical Current

Links

JP2016533383A 2013-08-05 2014-08-05 最適化ａ−バルジを有する組換えベクター Pending JP2016526920A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361862433P 2013-08-05 2013-08-05
US61/862,433 2013-08-05
PCT/US2014/049831 WO2015021077A1 (en) 2013-08-05 2014-08-05 Recombinant vector with optimized a-bulge

Publications (2)

Publication Number Publication Date
JP2016526920A JP2016526920A (ja) 2016-09-08
JP2016526920A5 true JP2016526920A5 (enrdf_load_stackoverflow) 2017-09-14

Family

ID=52461883

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016533383A Pending JP2016526920A (ja) 2013-08-05 2014-08-05 最適化ａ−バルジを有する組換えベクター

Country Status (6)

Country Link
EP (1) EP3030659A4 (enrdf_load_stackoverflow)
JP (1) JP2016526920A (enrdf_load_stackoverflow)
CN (1) CN105579581A (enrdf_load_stackoverflow)
AU (1) AU2014306093A1 (enrdf_load_stackoverflow)
CA (1) CA2920049A1 (enrdf_load_stackoverflow)
WO (1) WO2015021077A1 (enrdf_load_stackoverflow)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
AU2020328507A1 (en) 2019-08-12 2022-03-17 Purinomia Biotech, Inc. Methods and compositions for promoting and potentiating T-cell mediated immune responses through ADCC targeting of CD39 expressing cells
JP7500715B2 (ja) * 2019-09-30 2024-06-17 シャンハイ インスティチュート オブ マテリア メディカ，チャイニーズ アカデミー オブ サイエンシーズ 動脈関連疾患を治療するための薬物およびその用途
TW202128775A (zh) 2019-10-16 2021-08-01 英商阿法克塔生命科學有限公司 PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
AU2021273253A1 (en) * 2020-05-11 2022-11-17 Abintus Bio, Inc. Vectors and methods for in vivo transduction
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
AU2022212007A1 (en) 2021-01-29 2023-09-07 Merck Sharp & Dohme Llc Compositions of programmed death receptor 1 (pd-1) antibodies and methods of obtaining the compositions thereof
WO2022234003A1 (en) 2021-05-07 2022-11-10 Avacta Life Sciences Limited Cd33 binding polypeptides with stefin a protein
TW202334196A (zh) 2021-10-07 2023-09-01 英商阿法克塔生命科學有限公司 Pd-l1結合多肽
EP4412711A1 (en) 2021-10-07 2024-08-14 Avacta Life Sciences Limited Serum half-life extended pd-l1 binding polypeptides
TW202400647A (zh) 2022-04-29 2024-01-01 美商普瑞諾生物科技公司 用於治療嗜酸性球驅動之疾病及病症的方法及組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937190A (en) * 1987-10-15 1990-06-26 Wisconsin Alumni Research Foundation Translation enhancer
US20050260568A1 (en) * 2004-04-30 2005-11-24 Min Gao Hepatitis C virus assays
US8829173B2 (en) * 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
MX357418B (es) * 2008-09-26 2018-07-09 Tocagen Inc Vectores de terapia genica y citosina deaminasas.
US20110020814A1 (en) * 2009-06-05 2011-01-27 Ipierian, Inc. Methods and compositions for selection of stem cells
SG176890A1 (en) * 2009-06-17 2012-01-30 Tocagen Inc Producer cells for replication competent retroviral vectors

Similar Documents

Publication Publication Date Title
JP2016526920A5 (enrdf_load_stackoverflow)
US11279949B2 (en) Recombinant vectors comprising 2A peptide
EP2909324B1 (en) Retroviral vector with mini-promoter cassette
US11788101B2 (en) Genomic insulator elements and uses thereof
US11230719B2 (en) Retroviral vector having immune-stimulating activity
ES2911448T3 (es) Vectores combinados y métodos para el tratamiento del cáncer
JP2012503986A5 (enrdf_load_stackoverflow)
JP2015533510A5 (enrdf_load_stackoverflow)
JP2012503987A5 (enrdf_load_stackoverflow)
JP2024045608A (ja) 制御性ｒｎａを発現させるためのベクターシステム
Ku et al. Lentiviral vector induces high-quality memory T cells via dendritic cells transduction
JP2019503653A5 (enrdf_load_stackoverflow)
Everson et al. Retroviral vector interactions with hematopoietic cells
TWI817997B (zh) 結合至階段特異性胚胎抗原4 (ssea4)之嵌合抗原受體及其用途
Hoang-Le et al. A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy
Weber et al. Retroviral vectors
Abaan et al. Gene therapy in human breast cancer
US11970708B2 (en) Gene therapy vector with minimizing recombination, recombinant retrovirus comprising the vector, and pharmaceutical composition for preventing or treating cancer comprising the recombinant retrovirus
EP4249596A1 (en) New gene recombinant vaccinia virus and utilization thereof
RU2697797C2 (ru) Генетическая конструкция для индукции пролиферации периферических моноцитов in vitro
CN1162643A (zh) 用于癌症治疗的分子嵌合体的制备方法及应用
HK40034205A (en) Chimeric antigen receptors that bind to ssea4 and uses thereof
WO2018073307A1 (en) Mlv-based gene therapy with mutated integrase coupled to peptides